Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Biochemistry of the Eye 2nd edition_Whikehart_2003

.pdf
Скачиваний:
2
Добавлен:
28.03.2026
Размер:
10.32 Mб
Скачать

BUTTERWORTH-HEINEMANN

An Imprint of Elsevier Science

The Curtis Center

Independence Square West

Philadelphia, Pennsylvania 19106-3399

Copyright © 2003, 1994 Elsevier Inc. All Rights Reserved

No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writting from the publisher.

Library of Congress Cataloging-in-Publication Data

Whikehart, David R.

Biochemistry of the eye/David R. Whikehart.–2nd ed. p. ; cm.

Includes bibliographical references and index. ISBN 0-7506-7152-1

1. Eye–Metabolism. 2. Eye–Physiology. I. Title.

[DNLM: 1. Eye–chemistry. 2. Eye–physiopathology. WW 101 W561b 2003]

QP475 .W48 2003 612.8′4–dc21

2002026298

Publishing Director: Linda Duncan

Managing Editor: Christie M. Hart

Project Manager: Mary B. Stermel

Printed in USA

Last digit is the print number: 9 8 7 6 5 4 3 2 1

Preface to the 2nd edition

It is a modest statement to say that much has happened in this area since the 1st edition appeared. A perusal through the literature will show that great strides have occurred in the understanding of many heretofore difficult sections of ocular biochemistry including: diabetes, visual transduction, chemical tissue degradation, immunochemistry, cataractogenesis, and so on.

This new edition continues the tradition of the former edition in perusing the basic parts of biochemistry first and then continuing on to describe those characteristics of biochemistry that are peculiar and characteristic to the eye. It is my philosophy that illustrations are of immense help in understanding difficult concepts and I have liberally included them throughout the book. Two new chapters on aqueous/ocular fluids and tissue degradation have been added. In the older chapters much updating and revision should be evident to those familiar with the first edition.

As always, the objective in putting together such a work is to increase the student’s and reader’s awareness of those biochemical structures and molecular events that influence the normal and pathological performance of the eye as an organ of vision. The complexity of all that is involved in vision and vision care can hardly be understood without some knowledge of the molecular events that go on in the eye.

David R. Whikehart

v

Acknowledgments

I am indebted to those students who have made suggestions about improving the book prior to publication. Gratitude is also expressed to my daughter, Erin Whikehart, who designed the cover, and to Brigette Bailey, who allowed me to photograph her eye for the cover. Finally, I am especially thankful to Christie Hart, the managing editor of Elsevier

Science (Butterworth-Heinemann Division) and to Karen Oberheim, formerly of Butterworth-Heinemann, for their long standing patience as I wrote this text.

vii

Color Plate 1

One of several proposed structures for

α-crystallin. The model shows bound rings of crystallin subunits laid on top of each other. The large subunit spheres are hydrophilic C-terminal domains while the small subunit spheres are hydrophobic N-terminal domains. Extending from the C-terminal domains are C-terminal peptide extensions that cover the central cavity where chaperone activity may take place. (Redrawn from Carver JA, Aquilina JA, and Truscott RJW: A possible chaperone-like quaternary structure for a-crystallin. Exp Eye Res 59: 231–234, 1994.)

C

cytosol

membranedisc

Phe/Tyr

(7 nm)

 

 

312

 

129

 

Ser/Ala

N

(18 nm)

 

 

Ala/Thr (14 nm)

 

Ala/Ser (3 nm)

extracellular space

Tyr/His (28 nm)

Glu #129, the site of attachment for the Schiff base 129 counterion

312

Lys #312, the site of covalent attachment for

11-cis retinal

 

Color Plate 2

Diagram of a red or green cone pigment protein inserted into a cone membrane showing the site of attachment of the Schiff base counter ion and covalent attachment for the 11-cis retinal. Also illustrated are shifts in color vision produced by a substitution of certain amino acids (e.g., Thr for Ala to produce a shift of 18 nm). (The figure was redrawn from Nathans J: The evolution and physiology of human color vision: insights from molecular genetic studies of visual pigments, Neuron 24:299–312, 1999.)

PANCREAS

ISLET

A or α cell (glucagon)

B or β cell (insulin)

D or δ cell (somatostatin)

Color Plate 3

Diagram of islet cells in the human pancreas. Essentially, three types of cells produce insulin (β cells), glucagon (α cells), and somatostatin (δ cells). A fourth type of cell (F) produces pancreatic polypeptide. All cell types secrete hormones that deal with carbohydrate (and other intermediate) metabolic control. (Based on a drawing in Williams G, Pickup JC: Handbook of diabetes, ed 2, Oxford, 1999, Blackwell Science; 27.)

capillary all-trans RETINOL (t)

all-trans

(t)

* RETINYL

 

ESTER

all-trans

11-cis

*

RETINOL

RETINOL

 

 

*

 

 

11-cis

 

(t)

RETINAL

 

(t)

 

(t)

 

all-trans

 

RETINOL

(t)

 

*

 

all-trans

 

RETINAL

11-cis

+

 

OPSIN

 

RETINAL

 

+

 

hν

OPSIN

 

 

RHODOPSIN

Color Plate 4

The processing and transport of vitamin A at PE (pigment epithelial) cells and photoreceptor outer segments. At PE cells retinol may be stored as an ester or transported to the outer segment. The transport between and within PE cells and photoreceptor outer segments of 11-cis retinal as well as between photoreceptor cells and PE cells of all-trans retinol makes use of other transport binding proteins (t), an interstitial retinol binding protein (IRBP) as well as an intracellular retinal binding protein (CRBP) as described by Hollyfield et al (1985). Metabolic transformations of the different vitamin A forms are enzymatically catalyzed (*) in both the PE and photoreceptor cells. See text for further explanations.

1 = Ca+ /recoverin bound to rhodopsin kinase 2 = Ca+/GCAPs bound to guanylate cyclase

(proposed)

= Ca+/calmodulin bound to gate protein

 

3

 

1

 

 

RK

 

ATP

P

 

arrestin

 

 

cGMP

*

cGMP

 

cGMP

 

+2

GMP

Ca

3

γ

 

 

 

 

 

 

 

 

α

β

α

 

2

 

 

γ

α

β

 

activatedrhodopsin

transducin(G t

activatedcGMP phosphodiesterase

activateguanylatecyclase

K+

ROS DISK

 

 

 

)

 

 

 

MEMBRANE

 

 

 

 

 

ROS

PLASMA

MEMBRANE

Na+ +Ca+2

GATE

PROTEIN

Na/Ca-K exchange

protein

Color Plate 5

Diagram of visual transduction showing roles proposed to be played by Ca+2 and cGMP in visual transduction. Cyclic GMP levels are maintained by guanylate cyclase during the dark current. Cyclic GMP levels are reduced by cGMP phosphodiesterase during visual transduction under the influence of light/ activated rhodopsin/Gt. Ca+2 ions bind to recoverin to inactivate rhodopsin kinase preventing inactivation of activated rhodopsin by phosphorylation at 1*. Ca+2 ions bind to GCAPS proteins to inactivate guanylate cyclase. Ca+2 ions bind to calmodulin in order to negatively modulate ion flow through the gate proteins. In essence, Ca+2 ions are self-modulating at higher concentrations by at least three known mechanisms. See text for further explanation.

M

G2

Checkpoints

Go

S

G1

 

CELL CYCLE

 

 

 

(G1 Phase held)

 

 

Rb

p63

 

E2F

 

p21 gene

Pi

p53

 

 

 

 

p21

 

 

 

cyclin D

 

 

+ CDK4

p73

 

Pi

 

 

Rb

S Phase

E2F

 

Color Plate 6

The cell cycle and some of the many biochemical pathways that influence it. A diagram of the cell cycle is shown in the upper part of the figure. In the resting stage, G1 or gap one, no synthetic processes leading to cell division occur. A subdivision of the G1 phase, known as Go also occurs in which the cell cannot enter into a synthetic process leading to cell division. Cells may be in Go, for example, when there is insufficient nourishment to begin DNA synthesis. In the S or synthesis phase, synthesis of new DNA (replication) occurs prior to cell division. The G2 phase (gap two), is an interphase prior to mitosis or cell division. In this phase there are four sets of chromosomes present. In mitosis (the M phase), the complex process of cell division occurs (see, for example, Lodish et al, 2000). The movement or commitment of a cell into its next phase occurs by passage through so called “checkpoints” or “restriction points,” which are determined by a variety of biochemical mechanisms. The lower part of the Figure illustrates one phase commitment mechanism for passage though the checkpoint from the G1 to the S phase. Such a mechanism involves the proteins E2F and Rb (right). When E2F and Rb are bound together, the cell is held at the G1 phase. When the Rb protein is phosphorylated by cyclin dependent kinase 4 (when cyclin D is bound to the kinase) the Rb and E2F proteins are released from each other and both promote checkpoint passage by the stimulation of mRNAs to make proteins necessary for the S phase of the cell cycle. Obviously any influence on the activity of the cyclin D/CDK4 complex will influence the ability of the cell to divide (i.e., to enter the S phase). Three proteins (of many such as KIP [kinase inhibitor proteins]) that are known to influence this complex are p53, p63, and p73. These proteins cause the synthesis of mRNA for p21 a protein that inhibits the cyclin D/CDK4 enzyme complex. Any defect in p53, for example, may allow the cyclinD/CDK4 enzyme complex to carry out unchecked catalysis to separate E2F and Rb at a high rate and allow uncontrolled cell division. This, in fact, occurs in some cancer cells in which p53 occurs in mutated and useless forms.